Evidence map›Paper›PMID 39427181›Full record

Observational studyMalaria journal2024

An observational analysis of the impact of deltamethrin + piperonyl butoxide insecticide-treated nets on malaria case incidence and entomological indicators in Ebonyi State, Nigeria, 2017-2021.

Kelly M Davis, Okefu O Okoko, Adedayo O Oduola, Petrus U Inyama, Chigozi J Uneke, Kelley Ambrose, Aklilu Seyoum, Perpetua Uhomoibhi, Dale A Rhoda, Caitlin B Clary and 7 more

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Kelly M DavisPMI VectorLink Project, PATH, 455 Massachusetts Ave NW, Suite 1000, Washington, DC, 20001, USA. kdavis@path.org.
Okefu O OkokoNational Malaria Elimination Programme, Abuja, Nigeria.
Adedayo O OduolaAbt Global, PMI VectorLink Project, Abuja, Nigeria.
Petrus U InyamaAbt Global, PMI VectorLink Project, Abuja, Nigeria.
Chigozi J UnekeDepartment of Medical Microbiology/Parasitology, Faculty of Basic Clinical Science, Ebonyi State University, Abakaliki, Nigeria.
Kelley AmbroseAbt Global, PMI VectorLink Project, Rockville, MD, USA.
Aklilu SeyoumAbt Global, PMI VectorLink Project, Rockville, MD, USA.
Perpetua UhomoibhiNational Malaria Elimination Programme, Abuja, Nigeria.
Dale A RhodaBiostat Global Consulting, Worthington, OH, USA.
Caitlin B ClaryBiostat Global Consulting, Worthington, OH, USA.
Justin MillarPATH, Seattle, WA, USA.
Megan LittrellPATH, Washington, DC, USA.
John H RogersU.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
Melissa YoshimizuU.S. President's Malaria Initiative, U.S. Agency for International Development, Washington, DC, USA.
Uwem InyangU.S. President's Malaria Initiative, U.S. Agency for International Development, Monrovia, Liberia.
Mark MaireU.S. President's Malaria Initiative, Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Monrovia, Liberia.
Sarah M BurnettPMI VectorLink Project, PATH, 455 Massachusetts Ave NW, Suite 1000, Washington, DC, 20001, USA.

Funding

USAID through the US President's Malaria Initiative (PMI) PMI VectorLink Project (USAID/PMI contract AID-OAA-1-17-00008)
6 · The paper itself

Abstract

backgroundIntense pyrethroid resistance threatens the effectiveness of the primary vector control intervention, insecticide-treated nets (ITNs), in Nigeria, the country with the largest malaria burden globally. In this study, the epidemiological and entomological impact of a new type of ITN (piperonyl-butoxide [PBO] ITNs) distributed in Ebonyi State were evaluated. The epidemiological impact was also compared to the impact of standard pyrethroid-only ITNs in Cross River State.

methodsA controlled interrupted time series analysis was conducted on monthly malaria incidence data collected at the health facility level, using a multilevel mixed-effects negative binomial model. Data were analysed two years before and after the PBO ITN campaign in Ebonyi State (December 2017 to November 2021). A pre-post analysis, with no comparison group, was used to assess the impact of PBO ITNs on human biting rates and indoor resting density in Ebonyi during the high transmission season immediately before and after the PBO ITN campaign.

resultsIn Ebonyi, PBO ITNs were associated with a 46.7% decrease (95%CI: -51.5, -40.8%; p < 0.001) in malaria case incidence in the 2 years after the PBO ITN distribution compared to a modelled scenario of no ITNs distributed, with a significant decrease from 269.6 predicted cases per 1000 population to 143.6. In Cross River, there was a significant 28.6% increase (95%CI: -10.4, 49.1%; p < 0.001) in malaria case incidence following the standard ITN distribution, with an increase from 71.2 predicted cases per 1000 population to 91.6. In Ebonyi, the human biting rate was 72% lower (IRR: 0.28; 95%CI 0.21, 0.39; p < 0.001) and indoor resting density was 73% lower (IRR: 0.27; 95%CI 0.21, 0.35; p < 0.001) after the PBO ITNs were distributed.

conclusionsThe epidemiological and entomological impact of the PBO ITNs underscore the impact of these ITNs in areas with confirmed pyrethroid resistance. These findings contribute to ongoing research on the impact of new types of ITNs in Nigeria, providing critical evidence for the Nigeria National Malaria Elimination Programme and other countries for future ITN procurement decisions as part of mass ITN campaign planning and malaria programming.

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsInterrupted Time Series AnalysisMalariaMosquito ControlMosquito VectorsNitrilesPiperonyl ButoxidePyrethrinsAnimalsHumansIncidenceNigeriadecamethrinInsecticidesNitrilesPiperonyl ButoxidePyrethrinsInsecticide-treated netsMalariaPiperonyl butoxideVector control

Identifiers

PMID39427181
PMCPMC11491013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.